Mental Practice and Therapeutic Exercise in Young Nulliparous Women

Sponsor
University of Valencia (Other)
Overall Status
Recruiting
CT.gov ID
NCT06073210
Collaborator
(none)
45
1
3
7
6.4

Study Details

Study Description

Brief Summary

Mental practice (both in isolation and also in combination with real practice) has been shown to improve somatosensory and motor variables but so far no study has taken it into the study of women's health. Through this study we want to offer some interesting data regarding the effectiveness of mental practice combined with physical practice.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Motor Imagery plus therapeutic exercise
  • Behavioral: Action observation plus therapeutic exercise
  • Behavioral: Sham action observation plus therapeutic exercise
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Mental Practice and Therapeutic Exercise in Young Nulliparous Women: A Randomized Controlled Trial
Anticipated Study Start Date :
Sep 30, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Therapeutic exercise plus motor imagery

This group will perform a therapeutic exercise programme (aerobic and strength training) to which motor imagery training will be added.

Behavioral: Motor Imagery plus therapeutic exercise
Aerobic exercise (20 minutes) and strengthening exercise (15 minutes) to which will be added a motor imagery intervention (imagining movements without actually doing them).

Experimental: Therapeutic exercise plus action observation

This group will perform a therapeutic exercise programme (aerobic and strength training) to which action observation training will be added.

Behavioral: Action observation plus therapeutic exercise
Aerobic exercise (20 minutes) and strengthening exercise (15 minutes) to which will be added a action observation intervention (observing movements without actually doing them).

Active Comparator: Therapeutic exercise

This group will perform a therapeutic exercise programme (aerobic and strength training) to which sham action observation training will be added.

Behavioral: Sham action observation plus therapeutic exercise
Aerobic exercise (20 minutes) and strengthening exercise (15 minutes) to which will be added a sham action observation intervention (observing space planets).

Outcome Measures

Primary Outcome Measures

  1. Pelvic Floor Muscle Strength [pre-intervention (T0), and inmmediate post-intervention (T1) (between the first and the second measurement, about 60 minutes have elapsed because it is done on the same day).]

    maximum pelvic floor strength

  2. Pain Pressure Threshold [pre-intervention (T0), and inmmediate post-intervention (T1) (between the first and the second measurement, about 60 minutes have elapsed because it is done on the same day).]

    Pain sensitivity

  3. Lumbopelvic Motor Control [pre-intervention (T0), and inmmediate post-intervention (T1) (between the first and the second measurement, about 60 minutes have elapsed because it is done on the same day).]

    Sensorimotor control of lower limbs

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • over 18 years of age and asymptomatic women.
Exclusion Criteria:
  • This study will exclude those who presented a respiratory pathology, cardiac, systematic, or metabolic disease, history of recent surgery, vertebral fracture, or osteoarticular disorders of the spine area.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ferran Cuenca Martínez Valencia Spain 46017

Sponsors and Collaborators

  • University of Valencia

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ferran Cuenca, PhD, University of Valencia
ClinicalTrials.gov Identifier:
NCT06073210
Other Study ID Numbers:
  • UV0001
First Posted:
Oct 10, 2023
Last Update Posted:
Oct 10, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 10, 2023